» Articles » PMID: 32843565

Defining Heterogeneity Among Women With Gestational Diabetes Mellitus

Overview
Journal Diabetes
Specialty Endocrinology
Date 2020 Aug 27
PMID 32843565
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Attention to precision medicine in type 2 diabetes (T2D) has provided two favored approaches to subclassifying affected individuals and parsing heterogeneity apparent in this condition: phenotype-based and genotype-based. Gestational diabetes mellitus (GDM) shares phenotypic characteristics with T2D. However, unlike T2D, GDM emerges in the setting of profound pregnancy-related physiologic changes in glucose metabolism. T2D and GDM also share common genetic architecture, but there are likely to be unique genetic influences on pregnancy glycemic regulation that contribute to GDM. In this Perspective, we describe efforts to decipher heterogeneity in T2D and detail how we and others are applying approaches developed for T2D to the study of heterogeneity in GDM. Emerging results reveal the potential of phenotype- and genotype-based subclassification of GDM to deliver the promise of precision medicine to the obstetric population.

Citing Articles

How should we define subtypes of gestational diabetes mellitus?.

Gobl C, Tura A Diabetologia. 2025; .

PMID: 39954058 DOI: 10.1007/s00125-025-06374-x.


Subtypes of Gestational Diabetes Mellitus Are Differentially Associated With Newborn and Childhood Metabolic Outcomes.

Osmulski M, Yu Y, Kuang A, Josefson J, Hivert M, Scholtens D Diabetes Care. 2025; 48(3):390-399.

PMID: 39787502 PMC: 11870284. DOI: 10.2337/dc24-1735.


Gestational Diabetes, the Human Milk Metabolome, and Infant Growth and Adiposity.

Nagel E, Pena A, Dreyfuss J, Lock E, Johnson K, Lu C JAMA Netw Open. 2024; 7(12):e2450467.

PMID: 39666338 PMC: 11638796. DOI: 10.1001/jamanetworkopen.2024.50467.


Gestational Diabetes: An Update 60 Years After O'Sullivan and Mahan.

McIntyre H, Kampmann U, Clausen T, Laurie J, Ma R J Clin Endocrinol Metab. 2024; 110(1):e19-e31.

PMID: 39389786 PMC: 11651698. DOI: 10.1210/clinem/dgae709.


Analysis of early-pregnancy metabolome in early- and late-onset gestational diabetes reveals distinct associations with maternal overweight.

Masalin S, Klavus A, Rono K, Koistinen H, Koistinen V, Karkkainen O Diabetologia. 2024; 67(11):2539-2554.

PMID: 39083240 PMC: 11519293. DOI: 10.1007/s00125-024-06237-x.


References
1.
. 2. Classification and Diagnosis of Diabetes: . Diabetes Care. 2019; 43(Suppl 1):S14-S31. DOI: 10.2337/dc20-S002. View

2.
Udler M, McCarthy M, Florez J, Mahajan A . Genetic Risk Scores for Diabetes Diagnosis and Precision Medicine. Endocr Rev. 2019; 40(6):1500-1520. PMC: 6760294. DOI: 10.1210/er.2019-00088. View

3.
Bonomo M, Cetin I, Pisoni M, Faden D, Mion E, Taricco E . Flexible treatment of gestational diabetes modulated on ultrasound evaluation of intrauterine growth: a controlled randomized clinical trial. Diabetes Metab. 2004; 30(3):237-44. DOI: 10.1016/s1262-3636(07)70114-3. View

4.
Law G, Alnaji A, Alrefaii L, Endersby D, Cartland S, Gilbey S . Suboptimal Nocturnal Glucose Control Is Associated With Large for Gestational Age in Treated Gestational Diabetes Mellitus. Diabetes Care. 2019; 42(5):810-815. DOI: 10.2337/dc18-2212. View

5.
Khera A, Chaffin M, Aragam K, Haas M, Roselli C, Choi S . Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat Genet. 2018; 50(9):1219-1224. PMC: 6128408. DOI: 10.1038/s41588-018-0183-z. View